KM-023

· Kamari Pharma Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KM-023, covering 2012-07-26 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome. [Phase 1]